0000897069-25-001448.txt : 20250909 0000897069-25-001448.hdr.sgml : 20250909 20250909174246 ACCESSION NUMBER: 0000897069-25-001448 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250903 FILED AS OF DATE: 20250909 DATE AS OF CHANGE: 20250909 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Carmines Edward CENTRAL INDEX KEY: 0001916049 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32420 FILM NUMBER: 251304188 MAIL ADDRESS: STREET 1: C/O CHARLIE'S HOLDINGS, INC. STREET 2: 1007 BRIOSO DRIVE CITY: COSTA MESA STATE: CA ZIP: 92627 FORMER NAME: FORMER CONFORMED NAME: Carmines Ed DATE OF NAME CHANGE: 20220309 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Charlie's Holdings, Inc. CENTRAL INDEX KEY: 0001134765 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences EIN: 841575085 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1007 BRIOSO DR. CITY: COSTA MESA STATE: CA ZIP: 92627 BUSINESS PHONE: 949-570-0691 MAIL ADDRESS: STREET 1: 1007 BRIOSO DR. CITY: COSTA MESA STATE: CA ZIP: 92627 FORMER COMPANY: FORMER CONFORMED NAME: True Drinks Holdings, Inc. DATE OF NAME CHANGE: 20130122 FORMER COMPANY: FORMER CONFORMED NAME: BAZI INTERNATIONAL, INC. DATE OF NAME CHANGE: 20100803 FORMER COMPANY: FORMER CONFORMED NAME: XELR8 HOLDINGS, INC. DATE OF NAME CHANGE: 20070321 4 1 form4.xml X0508 4 2025-09-03 0001134765 Charlie's Holdings, Inc. CHUC 0001916049 Carmines Edward C/O CHARLIE'S HOLDINGS, INC. 1007 BRIOSO DRIVE COSTA MESA CA 92627 true false Common Stock 2025-09-03 4 P 0 20000 0.28 A 1881758 D Common Stock 2025-09-04 4 P 0 7000 0.3 A 1888758 D Common Stock 2025-09-08 4 P 0 7723 0.29 A 1896481 D Common Stock 2025-09-09 4 P 0 10000 0.32 A 1906481 D The price reported in Column 4 is a weighted average price. The prices purchase ranged from $0.27 to $0.28. The reporting person will provide the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each separate price within the range. The price reported in Column 4 is a weighted average price. The prices purchase ranged from $0.29to $0.30. The reporting person will provide the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each separate price within the range. The price reported in Column 4 is a weighted average price. The prices purchase ranged from $0.29 to $0.30. The reporting person will provide the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each separate price within the range. /s/ Edward Carmines 2025-09-09